Ignite Creation Date:
2025-12-24 @ 3:54 PM
Ignite Modification Date:
2026-01-05 @ 6:07 PM
Study NCT ID:
NCT03400592
Status:
UNKNOWN
Last Update Posted:
2018-01-17
First Post:
2015-10-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Nimotuzumab and Irinotecan as Second Line With Recurrent or Metastatic Gastric Adenocarcinoma
Sponsor:
Organization: